RxDoctor Payments Data

Rochelle Thompson, APRN

Nurse Practitioner · Topeka, KSNPI 1356588735

Payments from drug & device makers

$933in general payments, 2019–2025

Across 47 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$413
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$117
  • AbbVie$102
  • Amgen$68
  • Pfizer$57
  • Novo Nordisk$52
  • plus $125 from 5 others

What the payments were for

  • Food & beverage$933100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$933 in reported general payments places this provider in the 75th percentile of 1,326 nurse practitioner providers in Kansas.

See all nurse practitioner providers in Kansas

Medicare billing

Part B allowed, 2024
$6,676
Medicare patients
52
Services billed
79

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate22$32,722
EliquisApixaban21$22,079
JardianceEmpagliflozin21$22,027
OzempicSemaglutide14$14,380
Combivent RespimatIpratropium/Albuterol Sulfate11$8,246
Wixela InhubFluticasone Propion/Salmeterol14$4,301
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog12$3,878
BreynaBudesonide/Formoterol Fumarate12$3,588
Albuterol Sulfate HfaAlbuterol Sulfate84$3,572
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$3,401
Ventolin HfaAlbuterol Sulfate27$2,447
Gabapentin128$1,786
Omeprazole81$1,392
Atorvastatin Calcium194$1,199
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide114$1,006

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$57$22,07921 claims
Novo NordiskOzempic$52$14,38014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,326 nurse practitioner providers in Kansas.

Other nurse practitioner in Topeka

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →